Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03206905 · ClinicalTrials.gov registry record · NA
Safety, Tolerability, and Sustained Weight Loss of Endoscopic Sleeve Gastroplasty With Diet Modification and Exercise
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03206905 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 2 participants.
The verdict
NCT03206905, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effect of endoscopic sleeve gastroplasty (ESG) with diet and exercise, to diet and exercise alone, to see which is better in weight loss reduction. Investigators will also compare the effects of ESG to diet and exercise comorbidities such as diabetes, sleep apnea and high cholesterol as well as the various obesity related hormones.
Interventions
- PROCEDURE Endoscopic Sleeve Gastroplasty
- BEHAVIORAL Diet and Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03206905
The ClinicalTrials.gov registry entry for NCT03206905 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Endoscopic Sleeve Gastroplasty is the first listed.
NCT03206905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03206905 about?
NCT03206905 is a clinical study titled "Safety, Tolerability, and Sustained Weight Loss of Endoscopic Sleeve Gastroplasty With Diet Modification and Exercise". The purpose of this study is to compare the effect of endoscopic sleeve gastroplasty (ESG) with diet and exercise, to diet and exercise alone, to see which is better in weight loss reduction. Investigators will also compare the effects of ESG to diet and exercise comorbidities such as diabetes, slee...
What is the current status of trial NCT03206905?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2017-07-01. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03206905?
The interventions under investigation include: Endoscopic Sleeve Gastroplasty (PROCEDURE), Diet and Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03206905?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.